<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="210555">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00346411</url>
  </required_header>
  <id_info>
    <org_study_id>NA_00001359</org_study_id>
    <nct_id>NCT00346411</nct_id>
  </id_info>
  <brief_title>Health Outcomes in Rheumatoid Arthritis</brief_title>
  <official_title>Health Outcomes in Rheumatoid Arthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johns Hopkins University</source>
  <brief_summary>
    <textblock>
      This research is being done to help us learn about how different factors related to
      treatment affect rheumatoid arthritis (RA). This is not a treatment study. We will follow
      the patient for one year as he or she receives usual treatment from his or her
      rheumatologist. Up to 360 adults with RA may join this study.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Defined Population</observational_model>
    <time_perspective>Longitudinal, Prospective</time_perspective>
  </study_design_info>
  <enrollment>260</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and females age 19 or older

          -  Current active, adult-onset rheumatoid arthritis who meet ACR criteria for RA and
             have: (American College of Rheumatology [ACR] functional class I–III), defined as:

          -  3 or more swollen or tender joints and

          -  Morning stiffness of 45min or longer

          -  OR judged by their rheumatologist to have active disease

          -  No evidence of other inflammatory diseases (e.g., Crohn’s, IBS)

          -  Functional class I, II or III

        Exclusion Criteria:

          -  Individuals with significant cardiovascular disease (CHF, stroke, MI)

          -  Unwilling to have medications monitored and/or comply with protocol

          -  Not fluent in English

          -  Planning to move from area within next year or change health insurance (which would
             preclude ongoing care by JH rheumatologist)

          -  Enrolled in study evaluating efficacy of new or existing RA medications
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susan Bartlett, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Steffany Haaz, MFA</last_name>
    <role>Study Director</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Steffany Haaz, MFA</last_name>
    <phone>(410) 550-5216</phone>
    <email>shaaz1@jhmi.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Susan Bartlett, PhD</last_name>
    <phone>(410) 550-7775</phone>
    <email>bartlett@jhmi.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Johns Hopkins Bayview Campus</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steffany Haaz, MFA</last_name>
      <phone>410-550-5216</phone>
      <email>shaaz1@jhmi.edu</email>
    </contact>
    <contact_backup>
      <last_name>Susan Bartlett, PhD</last_name>
      <phone>(410) 550-7775</phone>
      <email>bartlett@jhmi.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Susan Bartlett, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Good Samaritan Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clifford Bingham, MD</last_name>
      <phone>410-532-4646</phone>
      <email>clifton.bingham@JHMI.edu</email>
    </contact>
    <investigator>
      <last_name>Clifford Bingham, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2006</verification_date>
  <lastchanged_date>June 28, 2006</lastchanged_date>
  <firstreceived_date>June 28, 2006</firstreceived_date>
  <keyword>rheumatoid arthritis</keyword>
  <keyword>mood</keyword>
  <keyword>adherence</keyword>
  <keyword>medication</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
